Date: 22 September 2021Court: Federal Court of AustraliaJudge: Perram J Background Deco Australia Pty Ltd (Deco) alleged infringement by Aliwood Pty Ltd (Aliwood) of Innovation...
New .au domain names will be available in Australia from 24 March 2022. From this date, individuals, businesses and organisations with an Australian presence will be able to...
Originally published in the IAM Saturday Opinion on 11 September 2021. Australia was recently thrust into the global IP limelight when the Federal Court controversially...
13 Sep 21 | Samsung Bioepis reported on a five-year follow-up study comparing ONTRUZANT® (trastuzumab biosimilar) with reference trastuzumab in early or locally advanced HER2...
02 Sep 21 | US | Amgen and Hospira appear ready to settle the ongoing dispute relating to Neupogen® (filgrastim). The matter was due to go to a jury trial on 20 September 2021....
A recent decision of Justice Burley in the Federal Court of Australia confirms that the bar for sufficiency and support has actually been raised by Australia’s 2012 ‘Raising the...
Pearce IP is proud to announce that Pearce IP’s Founding Principal and Executive Lawyer, Patent and Trade Mark Attorney, Naomi Pearce, has once again been recognised as a World...
26 Aug 21 | US | Two former executives of JHL Biotech plead guilty to conspiracy to steal trade secrets and commit wire fraud exceeding $101 million in the US District Court for...
Australia was recently thrust into the global IP limelight when the Federal Court controversially determined that an artificial intelligence (AI) system, DABUS, can be an...
24 Aug 21 | UCB announced that it has gained EU marketing approval for Bimzelx® (bimekizumab), an IL-17A and IL-17F inhibitor indicated for the treatment of adults with moderate...
17 Aug 21 | US | The USPTO Patent Trial and Appeal Board (PTAB) will review Amgen’s US 8,273,707 Patent (related to NEULASTA® (pegfilgrastim) in an IPR challenge brought by...
Date: 19 August 2021Court: Federal Court of AustraliaJudge: Burley J Background The ‘Bayer process’ has been used for over 130 years to extract alumina from bauxite to make...
The Australian Federal Court has confirmed in Merck Sharp & Dohme Corp. v Sandoz Pty Ltd [2021] FCA 947 that, when a patent covers two pharmaceutical substances of the...
05 Aug 21 | A new study reported that the safety profiles and pharmacokinetic parameters of Amgen’s ABP980 (biosimilar trastuzumab) and pertuzumab administered as an admixture in...
Date: 12 August 2021Court: Federal Court of AustraliaJudge: Jagot J Background Under Australian law, a patent term extension (PTE) must be based on the “first regulatory...
29 Jul 21 | US | The American Academy of Ophthalmology pushed back against insurance company pressure to use new bevacizumab biosimilars off-label in eye treatment as...
27 Jul 21 | Abenza and BioXpress Therapeutics announced they have formed a new partnership to support biosimilar development and manufacturing. 28 Jul 21 | Prestige BioPharma...
The Australian Federal Court in Thaler v Commissioner of Patents [2021] FCA 879 (30 July 2021) has determined that an artificial intelligence (AI) system, DABUS, can be an...
Pearce IP is proud to announce that Principal and Executive Lawyer, Patent Attorney and Trade Mark Attorney Naomi Pearce has been listed by WIPR Diversity as one of the world’s...
19 Jul 21 | Shanghai Henlius Biotech announced that the first patient has been dosed in its Ph I clinical trial of HLX04-O (proposed bevacizumab biosimilar) in the treatment of...
Date: 21 July 2021Forum: Australian Patent OfficeDelegate: Ranganath Subbarayan Background Australian Patent Application 2018243625 (Application) in the name of Advanced New...
12 Jul 21 | Boditech Med announced it has obtained export approval for AFIAS Adalimumab, a diagnostic kit which measures adalimumab levels in blood. The test is able to return a...
05 Jul 21 | Chong Kun Dang announced it has signed a commercialisation agreement with Menagen for Nesbell® (biosimilar darbepoetin alfa). Under the agreement, Chong Kun Dang will...
Although Australia has taken steps in recent years to harmonise its patent laws with those around the globe, significant differences remain. This means that patent practitioners...
Subscribe to our Pearce IP Blogs and BioBlast® to receive our updates via email.
